Published in Nature Nanotechnology
High-speed AFM imaging enables a semiquantitative, realistic description of the dynamic structure of intrinsically disordered proteins.
Published in Nature Nanotechnology
This Review summarizes the development history of Pt-based nanocatalysts and recent analytical studies to identify the technical issues in the automobile application, proposing promising strategies for overcoming the trade-offs among the efficiency,power density, and durability of polymer electrolyte fuel cells.
Published in Nature Nanotechnology
In a radiative Auger process, an excited electron relaxes by concomitant emission of a redshifted photon and energy transfer to another electron. Measuring radiative Auger processes in a quantum dot with single-photon resolution enables determination of the energy of single-electron levels as well as their lifetimes.
Published in Nature Nanotechnology
Chemoresistant cancer stem-like cells (CSCs) can be selectively killed by a nanoparticle, which releases an agent under hypoxic conditions that induces CSC differentiation, and a chemotherapeutic drug in response to reactive oxygen species in differentiating CSCs.
Published in Nature Nanotechnology
This Review discusses the progress and the remaining challenges for the clinical application of nanomaterial-based T-cell immunotherapies.
Published in Nature Nanotechnology
This Perspective describes the key advances in nanocatalysts that have led to the impressive electrochemical conversion of CO2 to useful products and provides benchmarks that others can use to compare their results.
Published in Nature Nanotechnology
Tolerogenic dendritic cells inhibit inflammatory responses against self-antigens, offering a therapeutic strategy for autoimmune diseases. This Review describes the nanotechnology-based approaches available to target dendritic cells and induce tolerogenic properties, highlighting applications in organ transplantation, multiple sclerosis and diabete...
Published in Nature Nanotechnology
Compared to cancer nanomedicine, cancer immune nanomedicine presents unique challenges stemming from the complexity of the tumour responses to immunotherapy. This Perspective describes some of the factors contributing to this complexity and offers thoughts on how nanomedicine researchers can include them in their experimental design.
Published in Nature Nanotechnology
Published in Nature Nanotechnology
Controlling immune cell activation would improve the efficiency of cell-based immunotherapies and reduce its associated risks. Here biodegradable particles are functionalized with DNA scaffolds for precise conjugation of a range of immunomodulating agents and applied ex vivo and in vivo for engineered immune cell modulation.
